Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria (NCT06865651) | Novartis Pharmaceuticals | 2025-05-22 |
Track Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) automatically
Every clearance here is in the API, with alerts when new ones post.